tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Salveen Richter, 139 are a HOLD (33.82%), 244 are a BUY (59.37%), 28 are a SELL (6.81%).
Analyst Salveen Richter, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 64.62% that have a potential upside of 46.23% achieved within 272 days.
Salveen Richter’s has documented 755 price targets and ratings displayed on 54 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on MRNA, Moderna at 21-Jul-2026.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 11/18/2019. The price target of $109 was fulfilled within 1 day with a profit of $13 (13.54%) receiving and performance score of 135.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Apr-2025
$36
$11.16 (44.93%)
$26
6 days ago
(21-Jul-2026)
4/5 (80%)
$10.57 (41.57%)
144
Hold Since 20-Jun-2022
$25
$0.16 (0.64%)
$24
6 days ago
(21-Jul-2026)
18/20 (90%)
$-0.43 (-1.69%)
119
Buy Since 23-Jun-2025
$36
$11.16 (44.93%)
$30
20 days ago
(07-Jul-2026)
0/7 (0%)
$9.8 (37.40%)
Buy Since 30-Jun-2026
$30
$5.16 (20.77%)
$29
27 days ago
(30-Jun-2026)
10/13 (76.92%)
$4.7 (18.58%)
275
Buy Since 21-Oct-2025
$35
$10.16 (40.90%)
$32
28 days ago
(29-Jun-2026)
0/4 (0%)
$9.8 (38.89%)
Which stock is Salveen Richter is most bullish on?
Which stock is Salveen Richter is most reserved on?
What Year was the first public recommendation made by Salveen Richter?
